MKI67 and triple-negative breast carcinoma: Overall, the results of our study revealed that higher levels of 5-mC and 5-hmC markers were associated with poorer response to neoadjuvant chemotherapy, higher Ki-67 proliferation levels, and higher tumor grade in triple-negative breast cancer tissues.